# OnCo record ruby (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/ruby/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "ruby", "NCT03981796" ;
  schema:name "RUBY / ENGOT-EN6 / GOG-3031"@en ;
  schema:description "Adding immunotherapy to first chemotherapy for advanced endometrial cancer extended life by more than a year on average, most dramatically in tumours with a broken DNA spell-checker."@en ;
  schema:url <https://onco.cc/trials/ruby/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03981796>, <https://www.nejm.org/doi/full/10.1056/NEJMoa2216334>, <https://www.annalsofoncology.org/article/S0923-7534(24)00721-X/fulltext> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2019-07-18" ;
  onco:cancers <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/endometrial-mmr-deficient/>, <https://onco.cc/cancers/advanced-recurrent-endometrial-cancer/>, <https://onco.cc/cancers/uterine-carcinosarcoma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/dostarlimab/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/> ;
  onco:companies <https://onco.cc/companies/gog-foundation/> ;
  onco:terms <https://onco.cc/terms/msi/> ;
  onco:people <https://onco.cc/people/mansoor-raza-mirza/> .